Towards enhanced transparency and accuracy of scientific reporting in biomedical journals

1. International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to medical journals. Available from URL: http://www.icmje.org/sop_1about.html-http: (accessed November 25, 2011)

2. CONSORT: Transparent Reporting of Trials. Available from URL: http://www.consort-statement.org/ (accessed November 25, 2011)

3. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 2010; 63: e1-37.

4. STROBE Statement: Strengthening the Reporting of Observational Studies Epidemiology. Available from URL: http://www.strobe-statement.org/ (Accessed November 25, 2011)

5. Liberati A, Altman D, Tetzlaff J et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:bmj.b2700

6. Backman S, Baker A, Bettie S et al. 2011 Canadian Journal of Anesthesia Guide for Authors. Can J Anesth 2011; 58: 668-96.

7. Szklo M, Neito FJ. Epidemiology: Beyond the Basics 2nd ed. Sudbury, MA: Jones & Bartlett; 2007.

8. Brasher P, Brant R. Sample size calculation in randomized trials: Common pitfalls. Can J Anesth 2007; 54:103-6.

9. van Belle G. Statistical Rules of Thumb 2nd ed. Hoboken, NJ: Wiley; 2008.

10. Brasher PM, Brant RF. Problems of multiplicity. Can J Anesth 2008; 55: 259-64.

11. Proschan MA, Waclawiw MA. Practical guidelines for multiplicity adjustment in clinical trials. Control Clin Trials 2000; 21: 527-39.

12. Papanikolaou PN, Ioannidis JP. Availability of large-scale evidence on specific harms from systematic reviews of randomized trials. Am J Med 2004; 117: 582-9.

13. Yazici Y. Some concerns about adverse event reporting in randomized clinical trials. Bull NYU Hosp Jt Dis 2008; 66(2): 1434-5.